AAAAAA

   
Results: 1-13 |
Results: 13
EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3071-3078
EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/, Thrombosis and haemostasis, 1997, pp. 788-788
RISK-FACTORS FOR VENOUS THROMBOEMBOLISM IN 202 WOMEN CARRIERS OF FACTOR-V-LEIDEN MUTATION AND ORAL-CONTRACEPTIVE USERS
Authors: DESMARAIS S CONARD J PLUBUREAU G HORELLOU MH ELALAMY I SAMAMA MM
Citation: S. Desmarais et al., RISK-FACTORS FOR VENOUS THROMBOEMBOLISM IN 202 WOMEN CARRIERS OF FACTOR-V-LEIDEN MUTATION AND ORAL-CONTRACEPTIVE USERS, Thrombosis and haemostasis, 1997, pp. 1525-1525
EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB-2 EXPRESSION IN NORMAL BREAST-TISSUE DURING THE MENSTRUAL-CYCLE
Authors: GOMPEL A MARTIN A SIMON P SCHOEVAERT D PLUBUREAU G HUGOL D AUDOUIN J LEYGUE E TRUC JB POITOUT P
Citation: A. Gompel et al., EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB-2 EXPRESSION IN NORMAL BREAST-TISSUE DURING THE MENSTRUAL-CYCLE, Breast cancer research and treatment, 38(2), 1996, pp. 227-235
SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS
Authors: PLUBUREAU G AMIRAL J GUIZE L SCARABIN PY
Citation: G. Plubureau et al., SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS, Lancet, 347(9000), 1996, pp. 549-549
HRT AND ACE ACTIVITY IN POSTMENOPAUSAL WOMEN
Authors: SCARABIN PY BILLAUD E PLUBUREAU G AGHER R
Citation: Py. Scarabin et al., HRT AND ACE ACTIVITY IN POSTMENOPAUSAL WOMEN, Lancet, 347(8994), 1996, pp. 122-122
WOMEN AT HIGH-RISK OF BREAST-CANCER - IS IT POSSIBLE TO DEFINE A GROUP OF WOMEN IN FRANCE WHO COULD PARTICIPATE IN A PREVENTION TRIAL
Authors: LE MG PLUBUREAU G
Citation: Mg. Le et G. Plubureau, WOMEN AT HIGH-RISK OF BREAST-CANCER - IS IT POSSIBLE TO DEFINE A GROUP OF WOMEN IN FRANCE WHO COULD PARTICIPATE IN A PREVENTION TRIAL, Contraception fertilite sexualite, 23(3), 1995, pp. 199-202
CHANGES IN HEMOSTATIC VARIABLES INDUCED BY ORAL-CONTRACEPTIVES CONTAINING 50 MU-G OR 30 MU-G ESTROGEN - ABSENCE OF DOSE-DEPENDENT EFFECT ONPAI-1 ACTIVITY
Authors: SCARABIN PY PLUBUREAU G ZITOUN D BARA L GUIZE L SAMAMA MM
Citation: Py. Scarabin et al., CHANGES IN HEMOSTATIC VARIABLES INDUCED BY ORAL-CONTRACEPTIVES CONTAINING 50 MU-G OR 30 MU-G ESTROGEN - ABSENCE OF DOSE-DEPENDENT EFFECT ONPAI-1 ACTIVITY, Thrombosis and haemostasis, 74(3), 1995, pp. 928-932
ASSOCIATION OF HORMONE REPLACEMENT THERAPY TO HEMOSTATIC VARIABLES INPOSTMENOPAUSAL WOMEN
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R GUIZE L AIACH M
Citation: Py. Scarabin et al., ASSOCIATION OF HORMONE REPLACEMENT THERAPY TO HEMOSTATIC VARIABLES INPOSTMENOPAUSAL WOMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS
Authors: PLUBUREAU G VISSAC AM LAROSA E BOURGEAT P AMIRAL I AGHER R GUIZE L SCARABIN PY
Citation: G. Plubureau et al., ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
PROGESTOGEN USE AND DECREASED RISK OF BREAST-CANCER IN A COHORT STUDYOF PREMENOPAUSAL WOMEN WITH BENIGN BREAST DISEASE
Authors: PLUBUREAU G LE MG SITRUKWARE R THALABARD JC MAUVAISJARVIS P
Citation: G. Plubureau et al., PROGESTOGEN USE AND DECREASED RISK OF BREAST-CANCER IN A COHORT STUDYOF PREMENOPAUSAL WOMEN WITH BENIGN BREAST DISEASE, British Journal of Cancer, 70(2), 1994, pp. 270-277
HEMOSTATIC VARIABLES AND MENOPAUSAL STATUS - INFLUENCE OF HORMONE REPLACEMENT THERAPY
Authors: SCARABIN PY PLUBUREAU G BARA L BONITHONKOPP C GUIZE L SAMAMA MM
Citation: Py. Scarabin et al., HEMOSTATIC VARIABLES AND MENOPAUSAL STATUS - INFLUENCE OF HORMONE REPLACEMENT THERAPY, Thrombosis and haemostasis, 70(4), 1993, pp. 584-587
FACTOR-VII ACTIVATION AND ORAL-CONTRACEPTIVES
Authors: PLUBUREAU G SCARABIN PY BARA L MALMEJAC A GUIZE L SAMAMA M
Citation: G. Plubureau et al., FACTOR-VII ACTIVATION AND ORAL-CONTRACEPTIVES, Thrombosis research, 70(3), 1993, pp. 275-280
Risultati: 1-13 |